Zhongze Therapeutics
Pioneering advances in psychiatric and neurological therapies from discovery to commercialization.
Pioneering advances in psychiatric and neurological therapies from discovery to commercialization.
ZHONGZE Therapeutics is a clinical stage biotech company founded in 2021. The company focuses on pioneering advances in psychiatric and neurological therapies, from discovery to commercialization. Its slogan, "Pioneering advances in psychiatric and neurological therapies from discovery to commercialization," reflects its commitment to innovative and transformative therapies for both psychiatric and neurological disorders. The latest milestone for the company was a Seed Round investment on 21 April 2022, with funding from Cenova and 杭州千毅杰睿投资管理有限公司. ZHONGZE Therapeutics is poised to make a significant impact in the biotech industry, with its focus on addressing critical unmet needs in the field of psychiatric and neurological disorders.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 2 |
|
21 Apr 2022 |
No recent news or press coverage available for Zhongze Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.